Tradestie Institutional Equity Comparison Engine
CNSY vs PHIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PHIO Overall Edge
PHIO Captures Institutional Edge (3โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Phio Pharmaceuticals Corp. Common Stock (PHIO) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, CNSY trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus PHIO at 0.3x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CNSY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PHIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
PHIO
CNSY N/M vs PHIO 0.3x Fwd P/E
Growth & Margin Winner
PHIO
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
PHIO
1Y -79.5% vs -48.2% ยท 52W Pos 8% vs 2%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CNSY
US Equity
CNSY
Institutional Equity
$0.72
-24.24% 1D
Market Cap
N/A
1M Return
-57.65%
1Y Return
-79.55%
Forward P/E
N/M
Unified AI Score
47.6 / 100
HOLD
Tech 65.0
Fund 55.0
Flow 50.0
Mom 60.0
PHIO
NASDAQ
Phio Pharmaceuticals Corp. Common Stock
Pharmaceutical Preparations
$0.74
-4.02% 1D
Market Cap
$9.7M
1M Return
-15.05%
1Y Return
-48.25%
Forward P/E
0.3x
Unified AI Score
42.8 / 100
HOLD
Tech 26.0
Fund 48.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CNSY -79.55%
PHIO -48.25%
Spread: +51.39 pp (PHIO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CNSY TTM Op. Margin: N/A
PHIO TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CNSY vs PHIO. Trailing 12-month operating profitability (CNSY N/A vs PHIO 0.0%) and valuation multiples (CNSY N/M vs PHIO 0.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CNSY | PHIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $9.7M | Larger Scale | PHIO |
| Trailing P/E Ratio Valuation | N/M | 0.3x | Lower Multiple | PHIO |
| Forward P/E Ratio Valuation | N/M | 0.3x | Lower Multiple | PHIO |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | PHIO |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | PHIO |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | PHIO |
| Return on Equity (ROE) Capital Efficiency | N/A | -113.7% | Higher ROE | PHIO |
| 52-Week Range Position Momentum | 8% ($0โ$4) | 2% ($1โ$2) | Stronger Trend | CNSY |
| Beta / 30D Volatility Risk Regime | 2.54ฮฒ ยท 228% Vol | 1.05ฮฒ ยท 54% Vol | Lower Realized Risk | PHIO |
| Unified Institutional Score Composite Signal | 47.6 / 100 (HOLD) | 42.8 / 100 (HOLD) | Higher Composite | CNSY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CNSY vs PHIO Buy Guide
CNSY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PHIO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CNSY nor PHIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.